| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
Selective ATR inhibitor, could reduce Claspins role in checkpoint signaling by reducing ATR-mediated phosphorylation. | ||||||
SCH 900776 | 891494-63-6 | sc-364611 sc-364611A | 5 mg 10 mg | $255.00 $338.00 | ||
Chk1 inhibitor, could decrease the need for Claspin as Chk1 is a downstream target of the Claspin-mediated signaling pathway. | ||||||
UCN-01 | 112953-11-4 | sc-202376 | 500 µg | $246.00 | 10 | |
Inhibits Chk1, potentially diminishing the function of Claspin in checkpoint activation. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
Chk1 inhibitor, could bypass Claspins mediation by directly inhibiting its downstream effector. | ||||||
LY2603618 | 911222-45-2 | sc-364526 sc-364526A | 5 mg 50 mg | $214.00 $1809.00 | ||
Selective Chk1 inhibitor, might reduce the functional role of Claspin in DDR by targeting its partner kinase. | ||||||
PF 477736 | 952021-60-2 | sc-362781 sc-362781A | 5 mg 25 mg | $113.00 $423.00 | ||
ATR inhibitor, potentially affects Claspins activation role by inhibiting upstream kinase ATR. | ||||||
Debromohymenialdisine | 75593-17-8 | sc-202127 | 100 µg | $100.00 | 2 | |
Inhibits checkpoint kinases including Chk1; this could reduce Claspins significance in checkpoint control. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor that also affects DNA-PK and ATR, potentially interfering with Claspin-related pathways. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $108.00 | 28 | |
ATM inhibitor, although not directly linked to Claspin, ATM inhibition can influence the overall DNA damage response network where Claspin operates. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $350.00 | 10 | |
DNA-PK inhibitor, potentially affecting the DNA damage response wherein Claspin has a regulatory role. | ||||||